Dr. David Kim Tjung Surjo – CEO

 

Background

Dr. David Surjo brings over 20 years of leadership experience in clinical drug development and GMP manufacturing to GOC Nexus. His career spans a diverse range of roles across CROs, CDMOs, and pioneering cannabis ventures, where he has successfully built and led EU-GMP certified production facilities. Renowned for his strategic vision and ability to forge impactful partnerships, David steers GOC Nexus with a commitment to innovation and operational excellence.

David’s industry expertise in the life science covers marketing, sales, contract management, corporate development, operations, and regulatory affairs. His transition into the medical cannabis industry was driven by a passion for innovation in phytopharmaceuticals—developing processes that preserve the plant’s original chemovar while meeting the highest GMP standards. His leadership combines scientific rigour with a forward-thinking, cross-functional approach that empowers interdisciplinary teams and drives projects to success.

David’s academic journey began with a degree in Biology from the University of Hanover, followed by a PhD in Biology from the University of Cologne. His early research focused on neurodegeneration, behavioural changes, and the use of opioid-based treatments for premature infants—work that inspired his deep interest in the therapeutic potential of medicinal cannabis.

Motivated by a strong belief in the medical value of cannabis and the urgent need for innovative patient care solutions, David is dedicated to advancing the field with integrity and expertise. His broad skill set and collaborative mindset make him a driving force behind GOC Nexus’s mission to set new standards in medical cannabis and life sciences.